Patients to trial tapeworm drug to protect them from Covid
Bristol trial part of a national initiative to help prevent covid infections in kidney patients.
Full Article
Patients to trial tapeworm drug to protect them from Covid
Bristol Post
0 shares
1 views
You might like
Related news coverage
Q BioMed has a winner in cancer bone pain drug Strontium89 and a deep pipeline of biomedical assets
Proactive Investors
Acquires undervalued biomedical assets to accelerate their development Developing drugs and therapies to treat pediatric nonverbal..
-
NA Proactive news snapshot: Alternus Energy, Bioasis Technologies, Highgold Mining, Western Magnesium, Mindset Pharma UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Plurilock Security, American Eagle Gold, Playgon Games, Kenorland Minerals, TRACON Pharmaceuticals UPDATE …
Proactive Investors
-
5 Indian pharma companies would jointly conduct a clinical trial of COVID drug
Zee News
-
Coronavirus: India reports under 40,000 new cases after 102 days
MENAFN.com
Advertisement
More coverage
Hull kidney patients join trial to see if tapeworm drug protects from Covid-19
Hull Daily Mail
High-risk kidney patients can sign up for the study
Kidney patients join study on tapeworm drug to halt Covid
Tiverton Mid Devon Gazette
-
Covid: High risk kidney patients in tapeworm drug trial
BBC Local News
-
Tiziana Life Sciences upbeat on potential for coronavirus treatment
Proactive Investors